IL93936A - History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them - Google Patents

History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them

Info

Publication number
IL93936A
IL93936A IL9393690A IL9393690A IL93936A IL 93936 A IL93936 A IL 93936A IL 9393690 A IL9393690 A IL 9393690A IL 9393690 A IL9393690 A IL 9393690A IL 93936 A IL93936 A IL 93936A
Authority
IL
Israel
Prior art keywords
deoxo
epoxy
amino
mmol
erythromycin
Prior art date
Application number
IL9393690A
Other languages
English (en)
Hebrew (he)
Other versions
IL93936A0 (en
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL93936A0 publication Critical patent/IL93936A0/xx
Publication of IL93936A publication Critical patent/IL93936A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
IL9393690A 1989-03-28 1990-03-28 History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them IL93936A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32947389A 1989-03-28 1989-03-28

Publications (2)

Publication Number Publication Date
IL93936A0 IL93936A0 (en) 1990-12-23
IL93936A true IL93936A (en) 1994-06-24

Family

ID=23285572

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9393690A IL93936A (en) 1989-03-28 1990-03-28 History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them

Country Status (14)

Country Link
US (1) US5288709A (da)
EP (1) EP0465581B1 (da)
JP (1) JPH04504259A (da)
KR (1) KR920701229A (da)
AT (1) ATE128714T1 (da)
AU (1) AU623764B2 (da)
CA (1) CA2049359A1 (da)
DE (1) DE69022845T2 (da)
DK (1) DK0465581T3 (da)
ES (1) ES2080140T3 (da)
GR (1) GR1000519B (da)
IL (1) IL93936A (da)
NZ (1) NZ233117A (da)
WO (1) WO1990011288A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
FR2713226B1 (fr) * 1993-12-03 1996-01-05 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
EP1125935A3 (en) * 1995-08-03 2001-12-12 Dade Behring Inc. Quinidine conjugates and their use in immunoassays
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
EP1499326A1 (en) * 2002-04-25 2005-01-26 Abbott Laboratories Oxolide antibacterials
SI1532131T1 (sl) * 2002-08-29 2009-04-30 Pfizer Motilidne spojine
ES2278319T3 (es) * 2003-05-13 2007-08-01 Glaxo Group Limited Nuevos compuestos con 14 y 15 miembros en el anillo.
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310986D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
CN107365338B (zh) * 2016-08-12 2021-03-19 西安世纪盛康药业有限公司 一类红霉素a-6,9-9,12-螺缩酮衍生物及其制备方法和应用
CN114504585A (zh) * 2020-11-16 2022-05-17 中国人民解放军海军军医大学 一种大环内酯类衍生物在制备减重降糖药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1451798A (en) * 1973-08-02 1976-10-06 Ici Ltd Prostanoic acid derivatives
US3963696A (en) * 1975-02-21 1976-06-15 Abbott Laboratories 6,6A-AND 6,7-Anhydroerythromycin B and derivatives thereof
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
US5008249A (en) * 1985-08-31 1991-04-16 Kitasato Kenkyusho Therapeutic method of stimulating digestive tract contractile motion in mammals
SE519436C2 (sv) * 2001-04-09 2003-02-25 Anoto Ab Penna med på pennan löstagbart anordnade medel för byte av i pennan anordnat bläckstift, samt förfarande för stiftbyte

Also Published As

Publication number Publication date
KR920701229A (ko) 1992-08-11
DE69022845D1 (en) 1995-11-09
JPH04504259A (ja) 1992-07-30
DE69022845T2 (de) 1996-06-13
EP0465581A1 (en) 1992-01-15
AU5402890A (en) 1990-10-22
DK0465581T3 (da) 1996-02-12
EP0465581A4 (en) 1992-05-13
EP0465581B1 (en) 1995-10-04
ES2080140T3 (es) 1996-02-01
GR900100232A (en) 1990-07-31
CA2049359A1 (en) 1990-09-29
ATE128714T1 (de) 1995-10-15
WO1990011288A1 (en) 1990-10-04
GR1000519B (el) 1992-08-25
US5288709A (en) 1994-02-22
AU623764B2 (en) 1992-05-21
IL93936A0 (en) 1990-12-23
NZ233117A (en) 1991-05-28

Similar Documents

Publication Publication Date Title
EP0638585B1 (en) 5-o-desosaminylerythronolide a derivative
US4742049A (en) Semisynthetic erythromycin antibiotics
CA2253338C (en) 6-o-substituted erythromycins and method for making them
US7129221B2 (en) 6,11-bicyclic erythromycin derivatives
EP1015467B1 (en) 6,9-bridged erythromycin derivatives
EP0465581B1 (en) Erythromycin derivatives
EP0876388A1 (en) Tricyclic erythromycin derivatives
AU1286799A (en) 6,11-bridged erythromycin derivatives
US6420535B1 (en) 6-O-carbamate ketolide derivatives
US4740502A (en) Semisynthetic erythromycin antibiotics
EP0201166A1 (en) Erythromycin derivatives
EP1206476B1 (en) 9a-azalides with antibacterial activity
EP1007530A1 (en) 6-o-substituted erythromycin compounds and method for making same
CA2378671C (en) 6-o-carbamate ketolide derivatives
EP1328535B1 (en) Macrolides
US20070270484A1 (en) 3'-N-Substituted-3-O-Substituted Erythronolide a Derivatives
AU714176B2 (en) 3-deoxy-3-descladinose derivatives of erythromycins A and B
HU196823B (en) Process for producing n-hydroxy-11-aza-10-deoxo-10-dihydro-erythromycin-a-n'-oxide
CA2235942C (en) Tricyclic erythromycin derivatives
WO2001030793A1 (en) Hygromycin a prodrugs
EP0321185A2 (en) Erythromycin derivatives
MXPA00002216A (en) 3-descladinose 6-o-substituded erythromycin derivatives

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void